The need for registry-based studies in diabetes and stroke: A unique opportunity to understand whether diabetic treatments improve post-stroke outcome
Diabetes Obes Metab
.
2024 Apr 1.
doi: 10.1111/dom.15577.
Online ahead of print.
Authors
Vladimer Darsalia
1
,
Ellen Vercalsteren
1
,
Dimitra Karampatsi
1
,
Mihaela Oana Romanitan
1
,
Michael V Mazya
2
3
,
Thomas Nyström
1
,
Cesare Patrone
1
Affiliations
1
NeuroCardioMetabol Group, Department of Clinical Science and Education, Södersjukhuset, Internal Medicine, Karolinska Institutet, Stockholm, Sweden.
2
Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
3
Department of Neurology, Karolinska University Hospital, Stockholm, Sweden.
PMID:
38558509
DOI:
10.1111/dom.15577
No abstract available
Grants and funding
Hjärnfonden
Foundation for Geriatric Diseases at Karolinska Institutet
ALF (avtal om läkarutbildning och forskning)
Hamberg Angeby och Lennart Angebys Stiftelse
Swedish Stroke Foundation
Vetenskapsrådet
Hjärt-Lungfonden